(ON-DEMAND ACOI 2025) Prostate Cancer: Genetic Insights and Evidence-Based Treatment of Localized Disease

(ON-DEMAND ACOI 2025) Prostate Cancer: Genetic Insights and Evidence-Based Treatment of Localized Disease

  • Register
    • Non-member - $40
    • Member - $30
    • Resident/Fellow - $10
    • Student - Free!

    Continue

CME Credit Available:

This activity offers .75 1A AOA

Note: ACOI reports credits to the AOA at the beginning of each month.

Learning Objectives:

In this session, you'll learn how to:

  • Understand the genetic risk factors for prostate cancer. 
  • Understand guideline driven recommendations for germline genetic testing in patients with prostate cancer. 
  • Understand current treatment options for men with localized prostate cancer.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Dr. Daniel Isaac, DO has disclosed the following financial relationships: • Novartis: Consulting Fees- Ongoing

Release & Review Date: 

This activity is valid from January 1, 2026, until January 1, 2029.

Daniel Isaac, DO (he/him/his)

Assistant Professor

Michigan State University

Dr. Dan Isaac is an Assistant Professor of Medicine in the Division of Hematology/Oncology at Michigan State University College of Human Medicine. A Southeast Michigan native, Dr. Isaac earned his bachelor’s and master’s degrees in mechanical engineering and biomechanics from Michigan State University before completing medical school at Virginia Tech. He is currently the Associate Program Director for the Hematology/Oncology Fellowship at the Karmanos Cancer Institute at McLaren Greater Lansing and Director of Clinical Research in the Division of Hematology/Oncology. He also serves as a member of the Steering Committee for the Big Ten Cancer Research Consortium. His clinical interests focus on genitourinary malignancies.

Key:

Complete
Failed
Available
Locked
Acknowledgement
Agree to terms to continue.
Agree to terms to continue.
You must register to access.
Pre-Test
5 Questions  |  1 attempt  |  0/5 points to pass
5 Questions  |  1 attempt  |  0/5 points to pass
You must register to access.
Session
Select the "View On-Demand Recording" button to begin.  |  27 minutes
Select the "View On-Demand Recording" button to begin.  |  27 minutes
You must register to access.
Q&A with Hematology Oncology Panel
Recorded 10/09/2025  |  15 minutes
Recorded 10/09/2025  |  15 minutes
You must register to access.
Post-Test
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
You must register to access.
CME Certificate
Up to 0.75 medical credits available  |  Certificate available
Up to 0.75 medical credits available  |  Certificate available
You must register to access.
Session Evaluation
11 Questions
11 Questions
You must register to access.